HIMCH
ANIP icon

Hartford Investment Management Co (HIMCO)’s ANI Pharmaceuticals ANIP Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,411
Closed -$249K – 736
2018
Q3 		$249K Sell
4,411
-294
-6% -$18K 0.01% 670
2018
Q2 		$314K Buy
+4,705
New +$294K 0.01% 601

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s ANIP Position: Q4 2018 in Review

Hartford Investment Management Co (HIMCO) sold out of ANI Pharmaceuticals (ANIP) in Q4 2018, closing a stake of 4,411 shares — an estimated $249K sold.

Hartford Investment Management Co (HIMCO) first reported a position in ANIP in Q2 2018 and held it in 2 quarters. The position peaked at $314K in Q2 2018. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2018.

  • Hartford Investment Management Co (HIMCO) reported no remaining ANI Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 4,411 ANI Pharmaceuticals shares in Q4 2018, an estimated $249K.
  • Hartford Investment Management Co (HIMCO) first reported a position in ANI Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Hartford Investment Management Co (HIMCO)'s ANI Pharmaceuticals position peaked at $314K in Q2 2018.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2018.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2018, filed 4 Feb 2019.